References
- Barnes Le Jwr P, Sidransky D. World Health Organization classification of tumors. Lyon: Pathology & Genetics: Head and neck tumors;2005. p.254-258.
- Hamada T, Matsukita S, Goto M, Kitajima S, Batra SK, Irimura T, et al. Mucin expression in pleomorphic adenoma of salivary gland: A potential role for MUC1 as a marker to predict recurrence. J Clin Pathol. 2004;57(8):813-821.
- Soares AB, Altemani A, De Araujo VC. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: An attempt to predict recurrence of pleomorphic adenoma. J Oral Pathol Med. 2011;40(4):352-358.
- Phillips PP, Olsen KD. Recurrent pleomorphic adenoma of the parotid gland: Report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol. 1995;104(2):100-104.
- Kerry D, Olsen, Jean E. Lewis. Carcinoma ex pleomorphic adenoma: A clinicopathologic review. Head & Neck. 2001;23(9):705-712.
- Kim JW, Kwon GY, Roh JL, Choi SH, Nam SY, Kim SY, et al. Carcinoma ex pleomorphic adenoma of the salivary glands: Distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation. J Korean Med Sci. 2011;26(10):1277-1285.
- Gnepp DR. Malignant mixed tumors of the salivary glands: A review. Pathol Annu. 1993;28 Pt 1:279-328.
- Klijanienko J, El-Naggar AK, Servois V, Rodriguez J, Validre P, Vielh P. Mucoepidermoid carcinoma ex pleomorphic adenoma: nonspecific preoperative cytologic findings in six cases. Cancer. 1998;84(4):231-234.
- Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD. Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer. 1996;77(2):223-230.